Imipenem levels are not predictable in the critically ill patient - PubMed (original) (raw)
Imipenem levels are not predictable in the critically ill patient
Howard Belzberg et al. J Trauma. 2004 Jan.
Abstract
Background: Critically ill patients often demonstrate extremely unusual volumes of distribution (Vd) and half-lives (t1/2) of drugs. Imipenem is a widely used antibiotic in critically ill patients.
Methods: We performed high-performance liquid chromatography analysis of imipenem in samples from 50 critically ill patients treated with either 500 or 1,000 mg.
Results: Peak imipenem levels varied from 1.56 microg/mL to 58.8 microg/mL. Trough levels varied between 0.0 microg/mL and 15.62 microg/mL. Only 54% of patients maintained a trough level greater than 4 microg/mL. Both the Vd and the t1/2 of imipenem were much greater than observed in other patient populations.
Conclusion: The pharmacokinetic activity of imipenem in critically ill patients is different from that in other patient populations. There is a very weak correlation between dosage and serum concentrations. Therapeutic failures of imipenem may be because of unpredictable pharmacodynamics (Vd and t1/2) in critically ill surgical patients.
Similar articles
- Pharmacokinetics of aztreonam and imipenem in critically ill patients with pneumonia.
McKindley DS, Boucher BA, Hess MM, Croce MA, Fabian TC. McKindley DS, et al. Pharmacotherapy. 1996 Sep-Oct;16(5):924-31. Pharmacotherapy. 1996. PMID: 8888088 Clinical Trial. - Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.
Fish DN, Teitelbaum I, Abraham E. Fish DN, et al. Antimicrob Agents Chemother. 2005 Jun;49(6):2421-8. doi: 10.1128/AAC.49.6.2421-2428.2005. Antimicrob Agents Chemother. 2005. PMID: 15917542 Free PMC article. Clinical Trial. - Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N, Markantonis SL, Dimitrakis E, Panidis D, Boutzouka E, Karatzas S, Rafailidis P, Apostolakos H, Baltopoulos G. Markou N, et al. Clin Ther. 2008 Jan;30(1):143-51. doi: 10.1016/j.clinthera.2008.01.015. Clin Ther. 2008. PMID: 18343250 Clinical Trial. - Two decades of imipenem therapy.
Rodloff AC, Goldstein EJ, Torres A. Rodloff AC, et al. J Antimicrob Chemother. 2006 Nov;58(5):916-29. doi: 10.1093/jac/dkl354. Epub 2006 Sep 22. J Antimicrob Chemother. 2006. PMID: 16997845 Review. - Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens.
Scaglione F, Paraboni L. Scaglione F, et al. Int J Antimicrob Agents. 2008 Oct;32(4):294-301. doi: 10.1016/j.ijantimicag.2008.03.015. Epub 2008 Jul 14. Int J Antimicrob Agents. 2008. PMID: 18621508 Review.
Cited by
- Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimens.
Couffignal C, Pajot O, Laouénan C, Burdet C, Foucrier A, Wolff M, Armand-Lefevre L, Mentré F, Massias L. Couffignal C, et al. Br J Clin Pharmacol. 2014 Nov;78(5):1022-34. doi: 10.1111/bcp.12435. Br J Clin Pharmacol. 2014. PMID: 24903189 Free PMC article. Clinical Trial. - Bacterial resistance in India: Studying plasma antibiotic levels.
Pandhare A. Pandhare A. Indian J Crit Care Med. 2015 Oct;19(10):574-5. doi: 10.4103/0972-5229.167032. Indian J Crit Care Med. 2015. PMID: 26628820 Free PMC article. No abstract available. - Relationship of imipenem therapeutic drug monitoring to clinical outcomes in critically ill patients: a retrospective cohort study.
Wu Y, Lu Z, Liang P, Zhu H, Qi H, Zhang H. Wu Y, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):4791-4798. doi: 10.1007/s00210-023-02909-4. Epub 2023 Dec 28. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38153513 - Prospective determination of plasma imipenem concentrations in critically ill children.
Giannoni E, Moreillon P, Cotting J, Moessinger A, Bille J, Décosterd L, Zanetti G, Majcherczyk P, Bugnon D. Giannoni E, et al. Antimicrob Agents Chemother. 2006 Jul;50(7):2563-8. doi: 10.1128/AAC.01149-05. Antimicrob Agents Chemother. 2006. PMID: 16801447 Free PMC article. - Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
Gonçalves-Pereira J, Póvoa P. Gonçalves-Pereira J, et al. Crit Care. 2011;15(5):R206. doi: 10.1186/cc10441. Epub 2011 Sep 13. Crit Care. 2011. PMID: 21914174 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical